Medicare Enrolled

Dr. Thomas Hoffman, M.D.

Dermatology · Palo Alto, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
301 HIGH ST, Palo Alto, CA 94301
6509695600
In practice since 2006 (19 years)
NPI: 1063435741 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hoffman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoffman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hoffman

Dr. Thomas Hoffman is a dermatology specialist in Palo Alto, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hoffman performed 3,604 Medicare services across 1,407 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hoffman received a total of $16,012 from 39 pharmaceutical and/or device companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hoffman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in CA $16,012 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,604
Medicare services
Top 35% in CA for dermatology
1,407
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,925 $6 $13
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
428 $74 $130
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
418 $50 $128
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
186 $33 $64
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
162 $47 $83
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
104 $99 $224
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
100 $84 $160
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
58 $167 $326
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
56 $76 $161
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $95 $184
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
22 $305 $469
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
19 $153 $342
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
18 $151 $341
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
18 $52 $106
Light therapy to destroy precancerous skin growth
This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous.
16 $136 $293
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
12 $37 $87
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
12 $1 $2
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,012
Total received (2018-2024)
Avg $2,288/year across 7 years
Top 12% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
333
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,831 (55.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,181 (44.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,739
2023
$4,019
2022
$1,905
2021
$1,437
2020
$981
2019
$2,197
2018
$1,735

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,710
Organogenesis Inc.
$29
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$7,117
E.R. Squibb & Sons, L.L.C.
$1,091
Sun Pharmaceutical Industries Inc.
$722
PFIZER INC.
$711
Regeneron Healthcare Solutions, Inc.
$701
Janssen Biotech, Inc.
$700
Ortho Dermatologics, a division of Bausch Health US, LLC
$593
Galderma Laboratories, L.P.
$552
Celgene Corporation
$456
Lilly USA, LLC
$446
LEO Pharma Inc.
$401
Allergan Inc.
$360
Allergan, Inc.
$339
GENZYME CORPORATION
$194
Almirall LLC
$185
Biofrontera Inc.
$157
AbbVie, Inc.
$151
SANOFI-AVENTIS U.S. LLC
$140
Incyte Corporation
$94
Amgen Inc.
$88
UCB, Inc.
$88
Stemline Therapeutics Inc.
$86
EPI Health, LLC
$83
AbbVie Inc.
$83
DERMIRA, INC.
$80
Mayne Pharma Inc.
$69
SUN PHARMACEUTICAL INDUSTRIES INC.
$53
Merz North America, Inc.
$48
DUSA Pharmaceuticals, Inc.
$38
Organogenesis Inc.
$29
Arcutis Biotherapeutics, Inc.
$22
Journey Medical Corporation
$21
Novartis Pharmaceuticals Corporation
$20
Janssen Scientific Affairs, LLC
$18
MERZ NORTH AMERICA, INC.
$17
Mission Pharmacal Company
$17
Aclaris Therapeutics, Inc.
$16
Taro Pharmaceuticals USA, Inc.
$15
Dermavant Sciences, Inc.
$13
Top 3 companies account for 55.8% of all-time payments
Associated products mentioned in payments ›
20% · ADBRY · AKLIEF · ALTRENO · AMELUZ · ARAZLO · Ameluz · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · CIBINQO · CLODERM · COSENTYX · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ELZONRIS · ENSTILAR · EPIDUO FORTE · ESKATA · EUCRISA · Enbrel · HALOG (Halcinonide Cream · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · Klisyri · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tazorac · Tremfya · USP) 0.1% · VTAMA · Winlevi · XEOMIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Palo Alto?
Compare dermatologists in the Palo Alto area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
277
Per 100K population
14.6
County median income
$159,674
Nearest hospital
STANFORD HEALTH CARE
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hoffman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hoffman experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Hoffman performed 1,925 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hoffman receive payments from pharmaceutical companies?
Yes. Dr. Hoffman received a total of $16,012 from 39 companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoffman's costs compare to other dermatologists in Palo Alto?
Dr. Hoffman's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoffman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →